Abstract
Interventions to reduce the likelihood of relapse, or a return to substance abuse after a period of abstinence, are important components of substance abuse treatment. Treatment interventions for adolescence with substance use disorders should incorporate principles of relapse prevention. The relapse prevention model advanced by Marlatt and Gordon and others in the addiction field is a self-control model, based on a cognitive-behavioral approach. This model stands in contrast to a disease model, which many in the medical field have adhered to. This paper presents a summary of the key features of Marlatt and Gordons cognitive-behavioral approach to relapse prevention.
Keywords: Alcohol use disorders, treatment, substance use disorders, Interventions, relapse, abstinence, relapse prevention, addiction, self-control, cognitive-behavioral
Adolescent Psychiatry
Title: Relapse Prevention
Volume: 1 Issue: 2
Author(s): Richard Rosner
Affiliation:
Keywords: Alcohol use disorders, treatment, substance use disorders, Interventions, relapse, abstinence, relapse prevention, addiction, self-control, cognitive-behavioral
Abstract: Interventions to reduce the likelihood of relapse, or a return to substance abuse after a period of abstinence, are important components of substance abuse treatment. Treatment interventions for adolescence with substance use disorders should incorporate principles of relapse prevention. The relapse prevention model advanced by Marlatt and Gordon and others in the addiction field is a self-control model, based on a cognitive-behavioral approach. This model stands in contrast to a disease model, which many in the medical field have adhered to. This paper presents a summary of the key features of Marlatt and Gordons cognitive-behavioral approach to relapse prevention.
Export Options
About this article
Cite this article as:
Rosner Richard, Relapse Prevention, Adolescent Psychiatry 2011; 1 (2) . https://dx.doi.org/10.2174/2210676611101020131
DOI https://dx.doi.org/10.2174/2210676611101020131 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Treatment of Cannabis Dependence
Current Pharmaceutical Design Depression Rises the Risk of Hypertension Incidence: Discussing the Link through the Ca2+/cAMP Signalling
Current Hypertension Reviews Nanoparticle Delivery of Transition-Metal Chelators to the Brain: Oxidative Stress will Never See it Coming!
CNS & Neurological Disorders - Drug Targets Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research Therapies in Development for Non-Infectious Uveitis
Current Molecular Medicine Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online (Discontinued) siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes
Current Neurovascular Research Curcumin - Properties, Applications and Modification of Structure
Mini-Reviews in Organic Chemistry Verbal and Nonverbal Correlates for Depression: A Review
Current Psychiatry Reviews Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
Current Pharmaceutical Design Light Chain Amyloidosis – Current Findings and Future Prospects
Current Protein & Peptide Science Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Current Neurovascular Research Pharmacologic Role of Vitamin D Natural Products
Current Vascular Pharmacology Quantitative Analysis of Duloxetine and 1-Naphthol by Capillary Micellar Electrokinetic Chromatography
Current Analytical Chemistry Marine Products with Anti-Protozoal Activity: A Review
Current Clinical Pharmacology Design of Molecules Acting on the Serotonin Receptors
Letters in Drug Design & Discovery Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review
Current Cancer Therapy Reviews Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design